¶ Celia Lourenco
Dr. Celia Lourenco is a Canadian pharmacologist and public health official based in Ottawa, Ontario. She is the Director General of the Biologics and Genetic Therapies Directorate (BGTD) of the Health Products and Food Branch at Health Canada. In this role, she serves as an ex-officio representative on the National Advisory Committee on Immunization (NACI).[1] She is also a member of the Council of Regulators for the Drug Information Association (DIA).[2]
¶ History
Lourenco received a PhD in Pharmacology from the University of Toronto, where she attended from 1991-2000.[3]
¶ Career
Lourenco served as the Senior Executive Director of the Therapeutic Products Directorate (TPD) and held other management positions in the agency. She was Director of the Bureau of Gastroenterology, Infection and Viral Diseases;[4] Associate Director of the Bureau of Cardiology, Allergy and Neurological Sciences; Interim Director of the Office of Clinical Trials; Manager of Clinical Group 1 at the Office of Clinical Trials; and Senior Clinical Evaluator.[5]
Lourenco has represented Health Canada at the International Pharmaceutical Regulators Programme (IPRP).[6]
Lourenco became the Director General of the Biologics and Genetic Therapies Directorate (BGTD) in November 2018.[3:1]
Lourenco previously represented Health Canada at the Assembly and Management Committee of the International Council for Harmonization (ICH), where she served as Assembly and Management Committee Vice-chair.[7]
¶ External links
Public Health Agency of Canada. (2022, February 25). National Advisory Committee on Immunization (NACI): Membership and representation. Government of Canada. http://archive.today/2022.04.24-045738/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html ↩︎
Council of Regulators. DIA Global. Retrieved September 25, 2021, from https://web.archive.org/web/20210925084443/https://www.diaglobal.org/en/about-us/leadership-governance/Council-of-Regulators?Committeeid=42268555 ↩︎
Celia Lourenco, PhD. Canadian Society for Pharmaceutical Sciences. Retrieved April 23, 2022, from https://web.archive.org/web/20220424043122/http://www.cspscanada.org/wp-content/uploads/Celia-Lourenco-Bio.pdf ↩︎ ↩︎
Health Canada. (2016, October 3). Final Record of Decisions - June 26, 2015, Meeting with National Association of Pharmacy Regulatory Authorities (NAPRA). Government of Canada. http://archive.today/2022.04.24-045353/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/association-meetings/record-decisions-june-26-2015-national-association-pharmacy-regulatory-authorities.html ↩︎
Celia Lourenco. LinkedIn. Retrieved April 23, 2022, from https://www.linkedin.com/in/celia-lourenco-88a5bb13/details/experience/ ↩︎
IPRF agrees on a path forward and a new name – the International Pharmaceutical Regulators Programme (IPRP) – for the consolidation of its operations with the IGDRP. (2017, November 12). International Pharmaceutical Regulators Programme. http://archive.today/2022.04.24-063441/https://www.iprp.global/news/iprf-agrees-path-forward-and-new-name-international-pharmaceutical-regulators-programme-iprp ↩︎
Members. (2020, July 29). International Council for Harmonization. http://archive.today/2020.07.29-225138/https://www.ich.org/page/members ↩︎